Imagia Company
Imagene provides AI-based molecular testing for cancer, detecting in real-time, a broad range of cancerous biomarkers from the biopsy image
Funding Status:
Early Stage Venture
Industry:
Imaging
Investors Number:
4
Last Funding Date:
2022-05-02
Number Of Exists:
51-100
Founded Date:
2020-01-01
Headquarters:
Tel Aviv, Tel Aviv, Israel
Total Funding:
21500000
Last Funding Type:
Series A
Employee Number:
51-100